1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 | 24 | 25 | 26 | 27 | 28 | 29 | 30 | 31 | 32 | 33 | 34 | 35 | 36 | 37 | 38 | 39 | 40 | 41 | 42 | 43 | 44 | 45 | 46 | 47 | 48 | 49 | 50 | 51 | 52 | 53 | 54 | 55 |

---

According to the results from the study published in Primary Care Diabetes have shown that serum uric acid concentration is linked with the with insulin resistance and impaired insulin secretion in people at risk for developing type 2 di...

Read More

---

Study Found Real Time Analysis of Type-2 Diabetes

Release Date: 30 November 2020

A novel research is being carried out by University of Virginia’s School of Medicine which tests a new and unconventional way to manage Type 2 diabetes for those who can’t or don’t want to lose weight. They have designe...

Read More

---

Role of Oral Semaglutide in type-2 Diabetes from Managed Care Perspective

Release Date: 30 November 2020

The increase prevalence of diabetes is of global concern. There are substantial consequences of uncontrolled T2D, including microvascular complications that place patients at risk of chronic kidney disease, diabetic retinopathy, and diab...

Read More

---

Study have Found Genes which Promote Glioblastoma Invasiveness

Release Date: 30 November 2020

The most aggressive form of brain tumors is glioblastoma. These are generally associated with poor diagnosis and failure of surgery or radiotherapy in curing them. Researchers have always put efforts to identify molecular targets which p...

Read More

---

Encouraging Results of Tesetaxel in Patients with Metastatic Breast Cancer

Release Date: 30 November 2020

The phase-3 study results of  tesetaxel in patients with metastatic breast cancer (MBC), were presented in an oral presentation at the 2020 San Antonio Breast Cancer Symposium (SABCS).  Odonate Therapeutics, Inc has initiated C...

Read More

---

Novel Gene Therapies for Rare Diseases in Development

Release Date: 29 November 2020

The investigators are rapidly developing next generation of gene therapies to treat rare disease. The above can be justified by the investment done by Generation Bio in January,2020 of about US $110 million which was raised to US $230 million in thr next six months. ...

Read More

---

Novel Adenovirus Gene in Placental Insufficiency

Release Date: 29 November 2020

Decreased uterine blood flow and lack of bioavailable VEGF due to placental insufficiency is the major cause of fetal growth restriction. The disease is incurable and causes serious neonatal morbidity and death. A recent study identified...

Read More

---

New Approach to Map Genetic Network by Using CRISPR Technology

Release Date: 29 November 2020

The novel CRISPR-Cas 9 technology has made possible to easily tweak out single gene to determine its effects on the cell or other gene. A group of researchers have developed a novel method to study the effect of multiple gene at a single...

Read More

---

CRISPR-LIGHT- Novel Technology in Brain Organoids

Release Date: 29 November 2020

Scientists have developed a new screening technique which uses organoids to test the effect of gene mutations on brain. To recognize the gene which control the cell growth, scientists have developed a variety of disruptive mutations and ...

Read More

---

Revolution in Managing Type-1 Diabetes by Monitoring Device

Release Date: 29 November 2020

University of Huddersfield have developed a novel design "The Sense Glucose Earring " which is non-invasive blood glucose monitor which can manage type-1 diabetes.  The novel diabetes-monitoring earring device requires a single...

Read More

---

Gene Therapy Application to Transform Vision Treatment in Mice Model

Release Date: 28 November 2020

A novel study indicates towards the discovery of a protein called as MCO1 opsin that is witnessed to restore vision in the blind mice using gene therapy applications. As per knowledge with respect to the protein, opsins are the proteins that are important in signalin...

Read More

---

Personalized Medicine to Thrive the Entire Cancer Therapeutics Market in Future

Release Date: 28 November 2020

At global level, personalized medicine for the treatment of cancer patients is leading to the development of novel chapter for the researchers and the patients. Researchers across the globe are now aiming at targeting HER2 pathway so tha...

Read More

---

Blenrep Drug to Undo Certain Changes Performed by Multiple Myeloma Cancer in Patients

Release Date: 28 November 2020

There has been a rise in the unmet demands of the cancer patients towards having an efficient therapy for the treatment of relapsed multiple myeloma. But the approval of the drug called as Blenrep for the cancer patients is estimated to ...

Read More

---

Targeting Adrenomedullin Hormone to Significantly Improve Life Expectancy in Patients Suffering from Different Cancer Types

Release Date: 28 November 2020

A novel study focuses towards improving the overall life expectancy as well as quality of the patients suffering from pancreatic cancer as well as breast cancer. Researchers are focused towards a hormone called as adrenomedullin, which i...

Read More

---

PCLX-001 to Help Researchers to Reduce the Growth of Cancer Cells in Blood Cancer

Release Date: 28 November 2020

The development of cancer cells in the human body is largely dependent on different unique signalling pathways. A novel study focuses towards development of a novel drug compound that is effective against blood cancers by targeting a sig...

Read More

---

1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 | 24 | 25 | 26 | 27 | 28 | 29 | 30 | 31 | 32 | 33 | 34 | 35 | 36 | 37 | 38 | 39 | 40 | 41 | 42 | 43 | 44 | 45 | 46 | 47 | 48 | 49 | 50 | 51 | 52 | 53 | 54 | 55 |